COGOI, Susanna
 Distribuzione geografica
Continente #
NA - Nord America 2.210
EU - Europa 556
AS - Asia 134
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 2.904
Nazione #
US - Stati Uniti d'America 2.193
UA - Ucraina 206
DE - Germania 88
IT - Italia 85
CN - Cina 77
FI - Finlandia 66
SE - Svezia 43
IE - Irlanda 32
TR - Turchia 22
GB - Regno Unito 18
CA - Canada 17
IN - India 15
VN - Vietnam 10
BE - Belgio 9
IR - Iran 5
PL - Polonia 3
JP - Giappone 2
TW - Taiwan 2
BG - Bulgaria 1
CL - Cile 1
EE - Estonia 1
ES - Italia 1
EU - Europa 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
NG - Nigeria 1
RS - Serbia 1
RU - Federazione Russa 1
TG - Togo 1
Totale 2.904
Città #
Woodbridge 290
Fairfield 287
Ann Arbor 199
Houston 179
Chandler 176
Ashburn 144
Jacksonville 141
Seattle 115
Wilmington 109
Cambridge 94
Dearborn 80
Udine 64
Beijing 36
Princeton 34
Dublin 32
Izmir 22
San Diego 19
Ottawa 13
Hefei 10
Ogden 10
Brussels 9
Dong Ket 9
Augusta 8
Jinan 7
San Mateo 7
Des Moines 6
Ardabil 5
Boardman 5
Norwalk 5
Bologna 4
Los Angeles 4
Nanjing 4
Washington 4
Fuzhou 3
Milan 3
Mumbai 3
Toronto 3
Auburn Hills 2
Denver 2
Frankfurt am Main 2
Kunming 2
Leawood 2
Monmouth Junction 2
Nanchang 2
New Delhi 2
New York 2
Poznan 2
Taipei 2
Tokyo 2
Andover 1
Badalona 1
Baotou 1
Belgrade 1
Borås 1
Chengdu 1
Giussano 1
Guangzhou 1
Guiyang 1
Hanoi 1
Harbin 1
Hebei 1
Helsinki 1
Lagos 1
Lomé 1
London 1
Montreal 1
Nanning 1
Phoenix 1
Redmond 1
Redwood City 1
Rende 1
Rome 1
Saint Petersburg 1
San Jose 1
Shanghai 1
Shenyang 1
Sofia 1
Tallinn 1
Trieste 1
Velletri 1
Vientiane 1
Warsaw 1
Xiamen 1
Šiauliai 1
Totale 2.202
Nome #
Anticancer activity of cationic porphyrins in melanoma tumour-bearing mice and mechanistic in vitro studies 180
G-quadruplex formation within the promoter of the KRAS proto-oncogene and its effect on transcription 129
Potent Apoptotic Response Induced by Chloroacetamidine Anthrathiophenediones in Bladder Cancer Cells 125
Anti-gene effect in live cells of AG motif triplex-forming oligonucleotides containing an increasing number of phosphorothioate linkages 122
Cellular uptake and binding of guanidine-modified phthalocyanines to KRAS/HRAS G-quadruplexes 117
RNA G-Quadruplexes in Kirsten Ras (KRAS) Oncogene as Targets for Small Molecules Inhibiting Translation 116
G4 DNA in ras genes and its potential in cancer therapy 113
Antigene property of PNA conjugated to the nuclear localization signal peptide 110
Enhanced G4-DNA binding of 5,10,15,20 (N-propyl-4-pyridyl) porphyrin (TPrPyP4): a comparative study with TMPyP4 108
Photoactivated cationic alkyl-substituted porphyrin binding to g4-RNA in the 5'-UTR of KRAS oncogene represses translation 108
G4-DNA formation in the HRAS promoter and rational design of decoy oligonucleotides for cancer therapy. 108
G-rich oligonucleotide inhibits the binding of a nuclear protein to the Ki-ras promoter and strongly reduces cell growth in human carcinoma pancreatic cells 104
Primer extension reactions as a tool to uncover folding motifs within complex G-rich sequences: analysis of the human KRAS NHE 102
Inhibition of gene expression by peptide nucleic acids in cultured cells 100
Enhancement of mdr2 gene transcription mediates the biliary transfer of phosphatidylcoline supplied by an increased biosynthesis in the pravastatin-treated rat 98
Synthesis and biological evaluation of new pentaphyrin macrocycles for photodynamic therapy 95
Downregulation of c-Ki-ras promoter activity by triplex-forming oligonucleotides endogenously generated in human 293 cells 94
PNA CONJUGATED TO HIGH MOLECULAR WEIGHT POLY(ETHYLENE GLYCOL):SYNTHESIS AND PROPERTIES 87
MAZ-binding G4-decoy with locked nucleic acid and twisted intercalating nucleic acid modifications suppresses KRAS in pancreatic cancer cells and delays tumor growth in mice 84
Purine twisted-intercalating nucleic acids: a new class of anti-gene molecules resistant to potassium-induced aggregation 81
Molecular strategies to downregulate gene expression 78
Antigene effect in K562 cells of a PEG-conjugated triplex-forming oligonucleotide targeted to the bcr/abl oncogene 67
PROTEIN hnRNP A1 AND ITS DERIVATIVE UP1 UNFOLD QUADRUPLEX DNA IN THE HUMNA KRAS PROMOTER: IMPLICATIONS FOR TRANSCRIPTION 63
The KRAS promoter responds to MYC-associated zinc finger and poly[ADP-ribose]polymerase 1 proteins which recognize a critical quadruplex-forming GA-element 63
Transcription inhibition of oncogenic KRAS by a mutation-selective peptide nucleic acid conjugated to the PKKKRKV nuclear localization signal peptide 62
Specific inhibition of bcr/abl gene expression in KYO-1 cells by antisense peptide nucleic acids 58
Antigene treatment direct against mutated Ki-ras with a PNA conjugated to a nuclear localisation derived peptide 57
Antiproliferative effect in chronic myeloid leukemia cells by antisense peptide nucleic acids 57
PEG-PNA:preparation and evalutation of PEG-conjugated peptide nucleic acids 49
HRAS is silenced by two neighboring G-quadruplexes and activated by MAZ, a zinc-finger transcription factor with DNA unfolding activity 40
Spectroscopy characterization of the oxidation control of the iso-pentaphyrin/pentaphyrin system 39
IDENTIFICATION OF A NEW G-QUADRUPLEX MOTIF IN THE KRAS PROMOTER AND DESIGN OF PYRENE-MIDIOFIED G4-DECOYS WITH ANTIPROLIFERATIVE ACTIVITY IN PANCREATIC CANCER CELL 37
STRUCTURAL POLYMORPHISM WITHIN A REGULATORY ELEMENT OF HUMAN KRAS PROMOTER:FORMATIONOF G4-DNA THAT IS RECOGNIZED BY NUCLEAR PROTEINS 34
Photoactivated cationic porphyrins binding to RNA quadruplex in the 5?-UTR of KRAS strongly suppress translation 27
Totale 2.912
Categoria #
all - tutte 8.060
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.060


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019201 0 0 0 0 0 0 0 0 0 0 122 79
2019/2020866 48 45 29 126 70 143 92 99 52 88 19 55
2020/2021468 12 47 11 58 26 54 5 53 61 26 86 29
2021/2022295 6 36 8 19 25 6 20 20 3 44 68 40
2022/2023353 37 43 2 59 40 83 0 20 46 5 12 6
2023/202491 12 4 5 6 17 25 0 1 16 5 0 0
Totale 2.912